Monte Rosa Therapeutics (GLUE) Asset Utilization Ratio (2024 - 2026)

Monte Rosa Therapeutics' Asset Utilization Ratio history runs 3 years deep, the most recent figure standing at 0.01 for Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 98.11% year-over-year to 0.01 in Q1 2026; TTM through Mar 2026 was 0.01, a 98.11% decrease from a year earlier, with the FY2025 full-year figure at 0.28, up 36.83% from the prior year.
• Asset Utilization Ratio declined to 0.01 in Q1 2026 per GLUE's latest filing, from 0.64 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.78 in Q2 2025 and bottomed at 0.0 in Q1 2024.
• The 3-year median for Asset Utilization Ratio is 0.2 (2024), against an average of 0.27.
• Across the five-year window, Asset Utilization Ratio jumped 10179.04% in 2025 and sank 98.11% in 2026, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.2 in 2024, then surged by 216.61% to 0.64 in 2025, then plunged by 98.86% to 0.01 in 2026.
• Per Business Quant, the three latest GLUE Asset Utilization Ratio figures stand at 0.01 (Q1 2026), 0.64 (Q4 2025), and 0.37 (Q3 2025).